Quantum Computing: A New Frontier in Healthcare and Drug Discovery

Quantum Computing: A New Frontier in Healthcare and Drug Discovery Published – August 21, 2026 08: 59 pm IST.

Key points

• Raju Gudla, Assistant Professor, Department of Computer Science and Engineering, SRM University -AP (Amaravati).
• A New Partnership Between Computing and Medicine.
• Think regarding the future in which scientists will be able to screen tens of thousands of medications by computers prior to developing even one lab sample.
• Modern computers process information based on the principle of bits – zeros and ones.
• One of the fields where it can be applied effectively is healthcare including drug discovery and personalized medicine.

By Dr. Raju Gudla, Assistant Professor, Department of Computer Science and Engineering, SRM University -AP (Amaravati).

Think regarding the future in which scientists will be able to screen tens of thousands of medications by computers prior to developing even one lab sample. Think regarding the ability of doctors to apply the patient's genetic and clinical data to prescribe the treatment tailored specifically for the individual patient. It may sound like science fiction, but a new technological innovation named quantum computing is making it closer to our everyday life.

Quantum computing differs greatly from traditional computing. Modern computers process information based on the principle of bits – zeros and ones. Quantum computers employ qubits which can produce employ of quantum mechanical effects like superposition and entanglement. Thus, quantum computers can solve specific challenges which become increasingly complex in their nature.

For context, the development of a new drug is an extensive and costly process which includes the identification of a target for drug action, discovery of molecules that can interact with the target, testing for efficacy and toxicity and ultimately going into clinical trials. One of the main challenges faced during drug development is the understanding of what occurs on the molecular level. Interactions of drug molecules with proteins, enzymes, and other biological structures occur in a complicated physical and chemical manner. While conventional computers can simulate most of these interactions, simulating the quantum-mechanical processes involved can be quite challenging. Here quantum computing comes in handy. Quantum algorithms for molecular simulation and quantum chemistry are being explored by researchers to obtain better insight into the molecular interaction processes. Recent studies have highlighted the importance of molecular simulation and drug-target interaction prediction as potential applications of quantum computing in pharmaceuticals.

Not all drugs work well only since of the good structure of its molecule. Drugs should have the ability to interact with the proper biological target in the proper way. Molecules of proteins are highly complex three-dimensional constructs, and the character of interaction between the drug and the protein will depend on the strength of this interaction. Thus, scientists consider the possibility of using quantum computing in modelling interaction of protein and molecules, considering the difficult-to-interpret electronic effects that are hard to evaluate using traditional methods. Such information will allow identifying promising molecules and understand what makes one molecule more effective than other molecules. From the practical point of view, this approach will be highly valuable. It will be feasible to limit the synthetic and experimental examination of substantial numbers of molecules and to select the best candidates through the computational method. It doesn't mean that quantum computers will replace the laboratories completely. They will be another significant tool in the process of drug development.

Notably, a fascinating area that could be explored using quantum machine learning is that of personalized medicine or precision medicine. Individuals suffering from the same medical condition may not necessarily react in the same way to a given drug. Factors such as the genetic makeup, lifestyle and environment among others can play a significant role in the way a drug affects a particular individual. With the amount of information being gathered regarding modern healthcare through genomics, patient records, imaging, etc., researchers are investigating if quantum computing and quantum machine learning can assist in analysing these enormous datasets and finding any useful patterns. In practice, the recent studies have looked at quantum computing in the context of multi-omics analysis, biomarker identification, disease prediction and drug discovery for achieving precision medicine. Going forward, this could aid in developing a healthcare system in which treatment decisions would be taken based on the individual patient's attributes.

For context, the applications do not end there with the discovery of a drug either. There are plenty of optimization difficulties in the healthcare sector. Who will be a part of the clinical trial? What locations will be best for the clinical trial? How will the individuals be allocated? How will the medical resources be efficiently applied?. There are quantum methods that are being researched to solve these kinds of challenges. Designing a clinical trial is an involved process that considers various factors. There might come a time where quantum methods could assist in solving some of these challenges. There could be a contribution of quantum computing in optimizing the treatments based on various criteria.

From the Laboratory to the Real World.

It should be remembered, nevertheless, that the distinction needs to be produced between the potential and the actual capability of quantum computing. Quantum computing is a relatively novel technology. Existing quantum hardware comes with certain restrictions such as the presence of noise, errors, the limited size, and the difficulty of sustaining quantum states. Therefore, efforts to create quantum computing hardware more efficient and improve other aspects such as algorithms and hybrid approaches continue. Despite the research which discussions concerning the application of quantum computing to drug design going forward, it should be remembered that at present quantum computers are far from being everyday tools in the field of pharmaceutical industry. The immediate future seems to belong to hybrid computing, the approach combining the employ of classical supercomputers and quantum computers.

In practice, a New Partnership Between Computing and Medicine.

In practice, the biggest impact of quantum computing on healthcare might turn out to be not any groundbreaking innovation, but rather an innovative approach to difficulty solving in science. In the field of drug development, it will enable scientists to explore the behaviour of molecules. In precision medicine, it can assist with biological data analysis. In clinical research, it will assist with hard optimization tasks. When it comes to healthcare, it will supplement existing innovations in artificial intelligence, high-performance computing, and others, in general. Nevertheless, from quantum computing algorithm to patient medication, there will be a long way to go. It will involve cooperation between computer scientists, physicists, chemists, biologists, doctors, drug researchers and policy makers. The only thing which is becoming increasingly obvious is that quantum computing is going from a notion explored by physicists to a real-life difficulty that is being considered in healthcare and life sciences. For context, the main goal here is simple, to develop better medicines and understand diseases in a more efficient way. Quantum computers alone will not solve every healthcare difficulty. But if the technology continues to mature, they could become an significant new instrument in medicine's technological toolbox, helping researchers tackle some of the most complex difficulties that conventional computing struggles to solve.

"This article is part of the programme."

For now, quantum Computing: A New Frontier in Healthcare and Drug Discovery remains the part of the story worth watching, and further updates are likely as more details are confirmed.